SMAD7 and melanoma: CERS4 expression was down-regulated in metastatic (late stage) head and neck squamous cell carcinoma (HNSCC), renal cell carcinoma, and melanoma (33), indicating that activation of CerS4/ceramide-Smad7 could target and inhibit tumor cell migration and invasion.